A detailed history of O'Shaughnessy Asset Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 3,702 shares of UTHR stock, worth $1.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,702
Previous 2,646 39.91%
Holding current value
$1.33 Million
Previous $842,000 57.48%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$311.04 - $363.55 $328,458 - $383,908
1,056 Added 39.91%
3,702 $1.33 Million
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $97,695 - $136,549
428 Added 19.3%
2,646 $842,000
Q1 2024

May 13, 2024

SELL
$210.76 - $249.51 $49,107 - $58,135
-233 Reduced 9.51%
2,218 $509,000
Q4 2023

Feb 09, 2024

BUY
$214.88 - $256.94 $32,446 - $38,797
151 Added 6.57%
2,451 $538,000
Q3 2023

Nov 13, 2023

BUY
$211.82 - $248.24 $22,664 - $26,561
107 Added 4.88%
2,300 $519,000
Q2 2023

Aug 11, 2023

SELL
$205.19 - $232.99 $11,080 - $12,581
-54 Reduced 2.4%
2,193 $484,000
Q1 2023

May 12, 2023

SELL
$212.99 - $276.17 $106,920 - $138,637
-502 Reduced 18.26%
2,247 $503,000
Q4 2022

Feb 10, 2023

SELL
$205.95 - $280.43 $13,592 - $18,508
-66 Reduced 2.34%
2,749 $764,000
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $7,318 - $8,790
-36 Reduced 1.26%
2,815 $589,000
Q2 2022

Aug 11, 2022

SELL
$174.81 - $241.14 $21,676 - $29,901
-124 Reduced 4.17%
2,851 $672,000
Q1 2022

May 13, 2022

SELL
$166.16 - $213.96 $360,401 - $464,079
-2,169 Reduced 42.17%
2,975 $534,000
Q4 2021

Feb 11, 2022

SELL
$184.32 - $216.08 $29,859 - $35,004
-162 Reduced 3.05%
5,144 $1.11 Million
Q3 2021

Nov 10, 2021

BUY
$179.86 - $214.88 $128,240 - $153,209
713 Added 15.52%
5,306 $979,000
Q2 2021

Aug 09, 2021

BUY
$170.47 - $211.93 $67,847 - $84,348
398 Added 9.49%
4,593 $824,000
Q1 2021

May 14, 2021

BUY
$153.94 - $174.85 $165,023 - $187,439
1,072 Added 34.33%
4,195 $702,000
Q4 2020

Feb 11, 2021

SELL
$101.87 - $151.79 $384,661 - $573,159
-3,776 Reduced 54.73%
3,123 $474,000
Q3 2020

Nov 12, 2020

BUY
$99.9 - $121.13 $542,956 - $658,341
5,435 Added 371.24%
6,899 $698,000
Q2 2020

Aug 13, 2020

BUY
$92.74 - $125.82 $135,771 - $184,200
1,464 New
1,464 $177,000
Q1 2020

May 13, 2020

SELL
$79.39 - $115.35 $46,204 - $67,133
-582 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$78.31 - $95.34 $45,576 - $55,487
582 New
582 $51,000
Q4 2018

Feb 12, 2019

SELL
$101.4 - $128.73 $709 - $901
-7 Closed
0 $0
Q3 2018

Nov 06, 2018

SELL
$113.81 - $129.46 $227 - $258
-2 Reduced 22.22%
7 $1,000
Q1 2018

May 08, 2018

SELL
$107.21 - $151.94 $64,433 - $91,315
-601 Reduced 98.52%
9 $1,000
Q4 2017

Feb 13, 2018

SELL
$118.58 - $151.28 $2.39 Million - $3.05 Million
-20,174 Reduced 97.07%
610 $90,000
Q3 2017

Nov 13, 2017

SELL
$114.6 - $136.81 $60,394 - $72,098
-527 Reduced 2.47%
20,784 $2.44 Million
Q2 2017

Aug 14, 2017

BUY
N/A
21,311
21,311 $2.77 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.